Maravai LifeSciences Holdings, Inc.
MRVI · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 10, 2026 | — | 48.67M | — | -0.05 | — |
| 2026 Q1 | May 7, 2026 | 65.84M | 53.00M | -0.02 | -0.05 | +23.10% |
| 2025 Q4 | February 25, 2026 | 49.87M | 49.05M | -0.24 | -0.07 | +9.20% |
| 2025 Q3 | November 6, 2025 | 41.63M | 49.06M | -0.14 | -0.06 | -0.69% |
| 2025 Q2 | August 11, 2025 | 47.40M | 50.08M | -0.12 | -0.06 | +30.58% |
| 2025 Q1 | May 12, 2025 | 46.85M | 44.01M | -0.15 | -0.07 | -2.83% |
| 2024 Q4 | March 20, 2025 | 56.41M | 57.79M | -0.06 | -0.03 | — |
| 2024 Q3 | November 7, 2024 | 65.20M | 56.64M | -0.09 | -0.01 | -35.27% |
| 2024 Q2 | August 7, 2024 | 73.40M | 71.63M | -0.08 | -0.04 | -6.87% |
| 2024 Q1 | May 8, 2024 | 64.18M | 60.55M | -0.11 | -0.03 | +11.16% |
| 2023 Q4 | February 22, 2024 | 74.14M | 64.38M | -0.05 | -0.01 | +63.60% |
| 2023 Q3 | November 7, 2023 | 66.87M | 75.52M | -0.02 | 0.00 | -31.69% |
| 2023 Q2 | August 7, 2023 | 68.91M | 71.13M | -0.06 | 0.01 | +0.73% |
| 2023 Q1 | May 8, 2023 | 79.03M | 79.72M | 0.03 | 0.04 | -13.02% |
| 2022 Q4 | February 22, 2023 | 204.71M | 204.93M | 0.35 | 0.34 | +8.17% |
| 2022 Q3 | November 2, 2022 | 191.26M | 195.11M | 0.37 | 0.32 | -5.53% |